JP2009535306A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535306A5
JP2009535306A5 JP2009506790A JP2009506790A JP2009535306A5 JP 2009535306 A5 JP2009535306 A5 JP 2009535306A5 JP 2009506790 A JP2009506790 A JP 2009506790A JP 2009506790 A JP2009506790 A JP 2009506790A JP 2009535306 A5 JP2009535306 A5 JP 2009535306A5
Authority
JP
Japan
Prior art keywords
variable region
region polypeptide
homology
vaccine
aiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009506790A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535306A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/067069 external-priority patent/WO2008060669A2/en
Publication of JP2009535306A publication Critical patent/JP2009535306A/ja
Publication of JP2009535306A5 publication Critical patent/JP2009535306A5/ja
Pending legal-status Critical Current

Links

JP2009506790A 2006-04-21 2007-04-20 鳥インフルエンザに対するワクチンおよび使用方法 Pending JP2009535306A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79380406P 2006-04-21 2006-04-21
PCT/US2007/067069 WO2008060669A2 (en) 2006-04-21 2007-04-20 Vaccine for avian influenza and methods of use

Publications (2)

Publication Number Publication Date
JP2009535306A JP2009535306A (ja) 2009-10-01
JP2009535306A5 true JP2009535306A5 (enExample) 2010-06-03

Family

ID=39402309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009506790A Pending JP2009535306A (ja) 2006-04-21 2007-04-20 鳥インフルエンザに対するワクチンおよび使用方法

Country Status (9)

Country Link
US (1) US7993655B2 (enExample)
EP (1) EP2010210A4 (enExample)
JP (1) JP2009535306A (enExample)
KR (1) KR20080109094A (enExample)
CN (1) CN101578111A (enExample)
AR (1) AR060565A1 (enExample)
BR (1) BRPI0710689A2 (enExample)
CA (1) CA2650091A1 (enExample)
WO (1) WO2008060669A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0713671A2 (pt) 2006-06-16 2013-12-03 Dow Agrosciences Llc Sequências de dna, vetores e proteínas de hemaglutinina de influenza aviária
US8050871B2 (en) 2006-10-24 2011-11-01 Samuel Bogoch Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus
US9408902B2 (en) 2007-05-30 2016-08-09 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
CN103122354B (zh) 2007-11-27 2018-03-23 麦迪卡格公司 表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp)
KR101956910B1 (ko) * 2008-01-21 2019-03-12 메디카고 인코포레이티드 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(VLPs)
US8771703B2 (en) 2008-07-08 2014-07-08 Medicago Inc. Soluble recombinant influenza antigens
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
WO2010123519A1 (en) * 2009-04-23 2010-10-28 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
CA2762042C (en) 2009-06-24 2012-11-20 Medicago Inc. Chimeric influenza virus-like particles comprising hemagglutinin
WO2011079282A1 (en) * 2009-12-23 2011-06-30 Vaxgene Corporation Immunoprotection by oral administration of recombinant lactococcus lactis mini-capsules
HRP20171564T1 (hr) 2009-09-22 2017-11-17 Medicago Inc. Postupak za pripremu biljnih čestica sličnih virusu (vlp)
EP2563389B1 (en) 2010-04-30 2015-07-08 Temasek Life Sciences Laboratory Limited Universal vaccine against h5n1 lineages
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
EP2734226A2 (en) 2011-07-20 2014-05-28 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
AU2013204906B2 (en) * 2012-03-12 2016-01-07 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
BR102013032129B1 (pt) 2012-12-13 2022-06-07 Dow Agrosciences Llc Método para identificar a presença de um polinucleotídeo de dna doador exógeno inserido dentro de um único locus genômico eucariótico alvo

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173410A (en) 1984-02-15 1992-12-22 Lubrizol Genetics Inc. Transfer vector
US4885248A (en) 1984-02-15 1989-12-05 Lubrizol Genetics, Inc. Transfer vector
CA1288073C (en) 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
ES2060646T3 (es) 1987-02-09 1994-12-01 Lubrizol Genetics Inc Virus rna hibrido.
EP0506763B1 (en) 1989-12-22 1999-06-02 E.I. Du Pont De Nemours And Company Site-specific recombination of dna in plant cells
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
JPH07200893A (ja) 1993-12-27 1995-08-04 Toshiba Corp 自動精算機
GB9615794D0 (en) * 1996-07-26 1996-09-04 Medical Res Council Mutant herpes simplex virus strains and uses thereof
US5916879A (en) * 1996-11-12 1999-06-29 St. Jude Children's Research Hospital DNA transcription unit vaccines that protect against avian influenza viruses and methods of use thereof
JP2000253876A (ja) 1999-03-08 2000-09-19 Dnavec Research Inc センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
AU5714601A (en) * 2000-04-19 2001-10-30 Univ Johns Hopkins Methods for prevention and treatment of gastrointestinal disorders
WO2002008386A2 (en) 2000-07-20 2002-01-31 The University Of Tennessee Research Corporation Materials and methods for the enhancement of effective root nodulation in legumes
DE10049587A1 (de) 2000-10-06 2002-05-02 Icon Genetics Ag Vektorsystem für Pflanzen
DE10061150A1 (de) 2000-12-08 2002-06-13 Icon Genetics Ag Verfahren und Vektoren zur Erzeugung von transgenen Pflanzen
DE10109354A1 (de) 2001-02-27 2002-09-05 Icon Genetics Ag Rekombinante virale Schaltersysteme
DE10121283B4 (de) 2001-04-30 2011-08-11 Icon Genetics GmbH, 80333 Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen
CA2450019A1 (en) 2001-06-08 2002-12-19 Icon Genetics, Inc. Production of proteins in plants
DE10129010A1 (de) 2001-06-13 2002-12-19 Icon Genetics Ag Verfahren und Vektoren zur Erzeugung von transgenen Pflanzen
DE10143205A1 (de) 2001-09-04 2003-03-20 Icon Genetics Ag Verfahren zur Proteinproduktion in Pflanzen
AU2002319157B2 (en) 2002-04-29 2008-01-03 Bayer Cropscience N.V. Process of producing environmentally safe transgenic organisms
JP2007526215A (ja) * 2003-05-05 2007-09-13 ダウ アグロサイエンス リミテッド ライアビリティー カンパニー トランスジェニック植物細胞に由来する安定な免疫予防的および治療的組成物ならびにその産生方法
DE602004028004D1 (de) * 2003-05-05 2010-08-19 Thompson Boyce Plant Res Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen
CA2816222A1 (en) 2003-06-16 2005-03-03 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
DE602004027403D1 (de) 2003-11-10 2010-07-08 Icon Genetics Ag Von rna-virus abgeleitetes pflanzenexpressionssystem

Similar Documents

Publication Publication Date Title
JP2009535306A5 (enExample)
Shoji et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza
JP2016539946A5 (enExample)
Jazayeri et al. Development of universal influenza vaccines targeting conserved viral proteins
JP2009526526A5 (enExample)
JP2012511579A5 (enExample)
NZ701881A (en) Vaccines for hsv-2
AR061484A1 (es) Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar
JP2014523878A5 (enExample)
EP3494989A1 (en) Composite antigenic sequences and vaccines
JP2008522621A (ja) 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン
JP2015517304A5 (enExample)
EP2552490A4 (en) INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF
KR102180774B1 (ko) H5N8형 재조합 인플루엔자 A 바이러스 및 이를 포함하는 clade 2.3.4.4A에 속하는 H5 혈청형 인플루엔자 A 바이러스에 대한 백신 조성물
Shoji et al. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants
JP2014139185A5 (enExample)
RU2014140731A (ru) Варианты гемагглютинина и нейраминидазы гриппа
JP2012517239A5 (enExample)
JP2013515490A5 (enExample)
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
Su et al. Emergence and pandemic potential of avian influenza a (H7N9) virus
CN101857872A (zh) 甲型流感病毒抗原决定区更换方法
Hajam et al. Oral immunization with an attenuated Salmonella Gallinarum encoding the H9N2 haemagglutinin and M2 ectodomain induces protective immune responses against H9N2 infection in chickens
Košík et al. A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection
Hatta et al. An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus